Clopamide structure
|
Common Name | Clopamide | ||
---|---|---|---|---|
CAS Number | 636-54-4 | Molecular Weight | 345.845 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C14H20ClN3O3S | Melting Point | 244-246ºC | |
MSDS | N/A | Flash Point | N/A | |
Symbol |
GHS08 |
Signal Word | Danger |
Use of ClopamideClopamide is an orally active thiazide-like diuretic agent that inhibits the sodium-coupled chloride cotransporter SLC12A3. Clopamide has the potential for hypertension and cardiac failure research[1][2]. |
Name | Clopamide |
---|---|
Synonym | More Synonyms |
Description | Clopamide is an orally active thiazide-like diuretic agent that inhibits the sodium-coupled chloride cotransporter SLC12A3. Clopamide has the potential for hypertension and cardiac failure research[1][2]. |
---|---|
Related Catalog | |
In Vitro | Clopamide is actively secreted by renal tubular cells and the True Tubular Excretion Fraction (TTEF) value is 10%[3]. |
In Vivo | The venoconstrictor response to bradykinin is attenuated after oral administration of Clopamide (0.5 mg/kg), and by concomitant local infusion of cyclosporine-A (1-10 μg/min) in conscious dogs[4]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Melting Point | 244-246ºC |
Molecular Formula | C14H20ClN3O3S |
Molecular Weight | 345.845 |
Exact Mass | 345.091400 |
PSA | 100.88000 |
LogP | 1.59 |
Index of Refraction | 1.613 |
Storage condition | 2-8°C |
HS Code | 2935009090 |
---|---|
Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. I: Investigation of mobile phase and MS conditions.
Anal. Chim. Acta 853 , 637-46, (2014) The conditions for the analysis of selected doping substances by UHPSFC-MS/MS were optimized to ensure suitable peak shapes and maximized MS responses. A representative mixture of 31 acidic and basic ... |
|
Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.
Anal. Chim. Acta 853 , 647-59, (2014) The potential and applicability of UHPSFC-MS/MS for anti-doping screening in urine samples were tested for the first time. For this purpose, a group of 110 doping agents with diverse physicochemical p... |
|
Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
Med. J. Aust. 150(11) , 646, 648, 651-2, (1989) In an open study that was conducted in general practice, 22 patients with previously-untreated mild hypertension received an average daily dose of 11.7 mg of pindolol over a 50-week study period. The ... |
EINECS 211-261-7 |
Brinaldix |
DT-327 |
4-Chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]-3-sulfamoylbenzamide |
Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)-, cis- |
CLOPAMIDUM |
ChlosudiMepriMyl |
Adurix |
MFCD00941495 |
4-Chloro-N-(2,6-dimethylpiperidino)-3-sulfamoylbenzamide |
3-(aminosulfonyl)-4-chloro-N-(2,6-dimethylpiperidin-1-yl)benzamide |
Aquex |
4-Chloro-N-(2,6-dimethylpiperidin-1-yl)-3-sulfamoylbenzamide |
Benzamide, 3-(aminosulfonyl)-4-chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]- |
Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)- |
4-Chloro-N-(2,6-dimethyl-1-piperidinyl)-3-sulfamoylbenzamide |